All data are based on the daily closing price as of October 14, 2024
p

Pharmicell

005690.KO
3.78 USD
-0.04
-1.05%

Overview

Last close
3.78 usd
Market cap
226.58M usd
52 week high
7.15 usd
52 week low
3.15 usd
Target price
12.91 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
12.8554
Price/Book Value
3.7828
Enterprise Value
225.11M usd
EV/Revenue
5.6355
EV/EBITDA
38.8771

Key financials

Revenue TTM
17.66M usd
Gross Profit TTM
6.40M usd
EBITDA TTM
-4.56M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
90.31B usd
Net debt
N/A usd

About

Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to improve the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC, a liver disease drug; Cellgram_ED for treating impotence; Hearticellgram_AMI, a cardiac disease drug; Cellgram_CKD for the treatment of chronic kidney disease; and Cellgram_AKI for the treatment of acute kidney disease. It develops and produces intermediates of raw material medicines, such as nucleosides and mPEGs; and low dielectric constant material, eco-friendly flame retardant, polyol synthesis catalyst, PET catalyst, etc. In addition, the company provides Half-Serum DMEM, as well as clinical development and commercialization services for new drugs. Further, it operates Twelve, a stem cell bank; and develops and sells stem cell culture media cosmetics. The company was formerly known as FcB2welve Co., Ltd and changed its name to Pharmicell Co., Ltd. in September 2011. Pharmicell Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
  • Symbol
    005690.KO
  • Exchange
    KO
  • Isin
    KR7005690003
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.pharmicell.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top